-Partnership with Kontrol's BioCloud® Technology to Provide Real-Time Detection of Airborne Pathogens to Create Safer Spaces- TORONTO--(BUSINESS WIRE)--Kontrol Technologies Corp. (NEO:KNR) (OTCQB:KNRLF) (FSE:1K8) ("Kontrol" or the "Company") a leader in
Company expects to enter clinic by 2023 and if approved, Delpor’s tizanidine implant will be the first minimally invasive, long-acting therapy for the maintenance of moderate to severe spasticity Expanded pipeline supports long-term growth in CNS incl
TORONTO--(BUSINESS WIRE)--$HUGE #RestoreFSD--FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9) (“FSD Pharma” or the “Company”), a life sciences holding company dedicated to building a portfolio of assets and biotech solutions, today announced
CAMBRIDGE, Mass.--(BUSINESS WIRE)--$VBIV--VBI Vaccines Inc. (Nasdaq: VBIV) (VBI), a biopharmaceutical company driven by immunology in the pursuit of powerful prevention and treatment of disease, today announced that Jeff Baxter, President and CEO, will pa
- Otenaproxesul’s acute pain clinical program set to begin early next quarter - Ended quarter with a $60 million cash position TORONTO--(BUSINESS WIRE)--Antibe Therapeutics Inc. (TSX:ATE, OTCQX:ATBPF), a clinical stage company leveraging its unique hyd
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Moderna Inc., a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today confirmed that Health Canada authorized the use of a booster dose of the Moderna COVID-19 vaccine (SPIKEVAX™) at th
-BioCloud Positive Detection Confirmed by Third-Party Laboratory Testing and Generates Significant Data and Analytics- TORONTO--(BUSINESS WIRE)--Kontrol Technologies Corp. (NEO:KNR) (OTCQB:KNRLF) (FSE:1K8) ("Kontrol" or the "Company") a leader in smart b
- Company to host conference call at 4:30pm EST today – TORONTO--(BUSINESS WIRE)--Cybin Inc. (NEO:CYBN) (NYSE American:CYBN) (“Cybin” or the “Company”), a biopharmaceutical company focused on progressing “Psychedelics to TherapeuticsTM”, to
- Q3 2021 Adjusted Total Revenue - $17.1 million - - Q3 2021 Adjusted EBITDA - $7.0 million - - Blexten Canadian Prescriptions Increased 16% Year-Over-Year - - Cambia Canadian Prescriptions Increased 5% Year-Over-Year - Miravo to Host Conference Call
Acquisition provides Flora with an immediate foothold in the North American cannabis market by acquiring a rapidly growing company with trailing 12-months revenue of $6.6M and year-over-year growth of 90% Acquisition diversifies Flora’s premium bran
Dr. Waylon Hunt took an unusual path to co-founding and leading a lab-based business, Intrinsic Analytics.
With a burgeoning scientific portfolio showing a unique ability to boost Akkermansia and Bifidobacteria levels, new products launching before the end of 2023, and international regulatory approvals, Solnul resistant starch “is primed to further penetrate
ElevateIP is a program funded by the Government of Canada aimed at equipping and supporting Canadian start-ups with the tools and knowledge to understand, strategize, protect, manage and leverage their intellectual property (IP)
Sign up for one of BAM's newsletter to learn more about bioscience, happenings in Manitoba's bioeconomy, industry conferences, and BAM training events.